Show simple item record

dc.contributor.authorQendri, Venetia
dc.contributor.authorBogaards, Johannes A
dc.contributor.authorBerkhof, Johannes
dc.date.accessioned2018-08-03T09:44:19Z
dc.date.available2018-08-03T09:44:19Z
dc.date.issued2018-07-26
dc.identifier.citationPricing of HPV vaccines in European tender-based settings. 2018 Eur J Health Econen
dc.identifier.issn1618-7601
dc.identifier.pmid30051152
dc.identifier.doi10.1007/s10198-018-0996-9
dc.identifier.urihttp://hdl.handle.net/10029/622111
dc.description.abstractVaccine price is one of the most influential parameters in economic evaluations of HPV vaccination programmes. Vaccine tendering is a cost-containment method widely used by national or regional health authorities, but information on tender-based HPV vaccine prices is scarce.
dc.language.isoenen
dc.rightsArchived with thanks to The European journal of health economics : HEPAC : health economics in prevention and careen
dc.titlePricing of HPV vaccines in European tender-based settings.en
dc.typeArticleen
dc.identifier.journalEur J Health Econ 2019; 20(2):271-80en
html.description.abstractVaccine price is one of the most influential parameters in economic evaluations of HPV vaccination programmes. Vaccine tendering is a cost-containment method widely used by national or regional health authorities, but information on tender-based HPV vaccine prices is scarce.


This item appears in the following Collection(s)

Show simple item record